Evaluating the Therapeutic Potential of Morin on Vaporic Acid Induced Autism in Wistar Rat

View at publisher Summarise with VIRAT
Authors: Valentine Ifebuchechukwu Ugwu, Ebunoha Chukwuka Stanley, Ezeugwu Lilian Nnenna, Uzoefuna Chima Casmir
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by deficits in social interaction, communication, and repetitive behaviors. Valproic acid (VPA) exposure during gestation in rodents’ models core features of ASD. This study evaluated the therapeutic potential of morin, a natural flavonoid, on VPA-induced autism in Wistar rats. Methods: Pregnant Wistar rats received intraperitoneal doses of VPA (80mg/kg) on gestational days 12 to 18. After weaning, offspring were divided into five groups: VPA only, VPA + low-dose morin, VPA + high-dose morin, VPA + folic acid, and negative control. Neurobehavioral assessments using the Open Field Test (OFT), Elevated Plus Maze (EPM), and Y-Maze were conducted on three post-weaning dates. Results: The VPA-only group exhibited reduced exploratory behavior, increased anxiety, and impaired spatial memory. High-dose morin and folic acid significantly improved behavioral outcomes, as indicated by increased line crossing, arm entries, and time spent in exploratory zones. Low-dose morin showed no significant effects. Conclusion: Morin, particularly at higher doses, demonstrated therapeutic potential in mitigating behavioral deficits associated with prenatal VPA exposure, comparable to folic acid. These findings support morin’s promise as a natural agent for ASD intervention. Keywords: Autism, valproic acid, morin, Wistar rats, neurobehavioral tests, folic acid, animal model.

Fields of Study & Subjects

Autism Spectrum Disorder Research Flavonoids in Medical Research Genetics and Neurodevelopmental Disorders

Publication details

Journal / source
INOSR EXPERIMENTAL SCIENCES
Volume
16
Issue
1
Pages
18–21
Publication date
22 March 2026
Language
EN